These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4336329)

  • 1. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI; Morse JH
    J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physicochemical and immunobiological properties of the dialysate antigen of Bordetella pertussis].
    Iagovkina VV; Moskalenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):11-5. PubMed ID: 2895557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytosis-promoting factor of Bordetella pertussis.
    Sato Y; Arai H
    Jpn J Med Sci Biol; 1975 Feb; 28(1):55-6. PubMed ID: 169413
    [No Abstract]   [Full Text] [Related]  

  • 5. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 7. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracted protective antigen of Bordetella pertussis. I. Preparation and properties of the solubilized surface of components.
    Helting TB; Blackkolb F
    Acta Pathol Microbiol Scand B; 1981 Apr; 89(2):93-101. PubMed ID: 6266198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1973 Jun; 7(6):992-9. PubMed ID: 4351972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed type hypersensitivity induced by LPF from Bordetella pertussis.
    Guadalupe Cortés JM; Juliano Y; Mendes NF; Mendes E
    Allergol Immunopathol (Madr); 1986; 14(4):311-7. PubMed ID: 2877558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 13. The stability of the protective antigen and histamine-sensitizing factor of Bordetella pertussis to acid and alkali.
    Jakus CM; McClure L; Wardlaw AC
    Can J Microbiol; 1968 Feb; 14(2):147-51. PubMed ID: 4296232
    [No Abstract]   [Full Text] [Related]  

  • 14. The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures.
    Morse SI; Bray KK
    J Exp Med; 1969 Mar; 129(3):523-50. PubMed ID: 4304138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymph and lymphocytes of mice.
    Morse SI; Riester SK
    J Exp Med; 1967 Apr; 125(4):619-28. PubMed ID: 4289740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. II. Adjuvant effect for the production of reaginic antibody in the rat.
    Tada T; Okumura K; Ochiai T; Iwasa S
    Int Arch Allergy Appl Immunol; 1972; 43(2):207-16. PubMed ID: 4342866
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine.
    Robbel L; Hungerer KD; Aktories K
    Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic reaction of Bordetella pertussis and leukocytic reaction in mice].
    Walecki H; Sitek K
    Med Dosw Mikrobiol; 1966; 18(2):111-5. PubMed ID: 4287625
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the serology of Bordetella pertusis. 3. Biological investigations of antigen fractions of ultrasonic extract obtained by column chromatography on DEAE-cellulose (author's transl)].
    Mebel S; Mucke W; Lapaeva IA; Zakharova MS
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(2):241-7. PubMed ID: 4133229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.